Clinical Trial Update: Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism [Phase 4]

View source ↗

Summary

Phase 4 randomized multicenter cross-over trial comparing Physioneal 35 to 40 on protein metabolism in patients with end-stage renal disease; the study has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Physioneal 35
• Physioneal 40

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Endstage Renal Disease | Phase 4 | Status: TERMINATED